US Patent Issued to Unlocked Labs on Aug. 11 for "Therapeutic engineered microbial cell system and methods for treating hyperuricemia and gout" (Wyoming Inventor)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,703,849, issued on Aug. 11, was assigned to Unlocked Labs (Laramie, Wyo.).

"Therapeutic engineered microbial cell system and methods for treating hyperuricemia and gout" was invented by Christoph Geisler (Laramie, Wyo.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to engineered microbial cells that have been engineered to include a uricase, a uric acid transporter, or both a uricase and a uric acid transporter. The engineered microbial cells of the present disclosure are useful in degrading uric acid inside the engineered microbial cell. The engineered microbial cells of the present disclosure are useful in methods of tre...